北信源(300352.SZ):取得9項發明專利證書
格隆匯 11 月 4日丨北信源(300352.SZ)公佈,公司及全資子公司於近日取得中華人民共和國國家知識產權局頒發的發明專利證書,分別為應用訪問行為異常檢測方法及系統,一種交換機准入認證方法、交換機及系統,文件安全監控方法、裝置及計算機,非法設備的發現方法和裝置,差錯處理方法及裝置,一種終端安裝包部署和實現方法與裝置,一種虛擬桌面的接入設備控制方法與裝置,一種數值融合模型構建方法及裝置,一種基於動態編譯的客户端軟件運行方法。
上述專利的取得對公司佈局網絡信息安全領域具有積極影響,是公司堅持持續創新的成果,有利於公司進一步完善知識產權保護體系,充分發揮自主知識產權優勢,促進技術創新,提升公司核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.